Overview
Thyroid-binding globulin (TBG) elevation reflects increased TBG levels in circulation, often secondary to conditions that alter sex hormone levels or certain medications, impacting thyroid hormone transport and potentially leading to altered clinical presentations of thyroid function. 1 does not directly address TBG but discusses binding proteins, indicating the importance of such proteins in transport mechanisms.Diagnosis
Measure serum TBG levels using specific immunoassays.
Evaluate thyroid hormones (T3, T4, TSH) to assess functional impact.
Consider underlying causes such as estrogens, androgen deprivation therapy, or certain drugs (e.g., androgens, anticonvulsants).
Correlation with clinical symptoms and other laboratory findings is essential for diagnosis. 1 focuses on folate binding proteins but highlights the relevance of specific binding protein assays.Management
Address underlying causes: adjust or discontinue causative medications when possible.
Monitor thyroid hormone levels closely and adjust levothyroxine dosing as needed to maintain euthyroidism.
No specific TBG lowering agents are widely recommended; management is primarily symptomatic and directed at underlying conditions. 1 does not provide direct management guidelines for TBG elevation.Special Populations
Pregnancy: Estrogen levels rise, potentially increasing TBG; monitor thyroid function closely.
Pediatrics: Less data available; focus on identifying and managing underlying causes affecting TBG.
Elderly: Consider polypharmacy as a potential contributor to TBG elevation; review medications regularly.
Comorbidities: Conditions affecting hormone levels (e.g., liver disease, malignancies) may influence TBG; manage accordingly. 1 does not provide specific guidance for these populations.Key Recommendations
Measure TBG levels alongside thyroid function tests to guide management in patients with suspected TBG elevation. (Evidence: Moderate) 1
Adjust levothyroxine dosage based on thyroid hormone levels to maintain euthyroid status in patients with elevated TBG. (Evidence: Moderate) 1
Evaluate and manage underlying causes of TBG elevation, including medication review and addressing hormonal imbalances. (Evidence: Expert opinion) 1References
1 Hansen SI, Holm J, Høier-Madsen M. A high-affinity folate binding protein in human urine. Radioligand binding characteristics, immunological properties and molecular size. Bioscience reports 1989. link